Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Application of Differentiation to Business01:29

Application of Differentiation to Business

Calculus offers essential techniques for businesses seeking to optimize pricing strategies and revenue. In this case, a bakery wants to determine the ideal price and daily sales volume to maximize revenue. By modeling how changes in price affect demand and revenue, the bakery can apply calculus to make data-driven decisions.The demand function relates the price per cupcake to the number of cupcakes sold and captures how lower prices increase sales. Based on market data, the demand function can...
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost of Treating Skin Problems in Patients with Diabetes Who Use Insulin Pumps and/or Glucose Sensors.

Diabetes technology & therapeutics·2019
Same author

Enhancing the fatty acid profile of milk through forage-based rations, with nutrition modeling of diet outcomes.

Food science & nutrition·2018
Same author

Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial.

European radiology·2016
Same author

How to Improve Your Paper With a Cost of Illness Analysis: Providing an Example on Bullying Among Social Care Workers in Elder Care.

Journal of occupational and environmental medicine·2015
Same author

[In Process Citation].

Ugeskrift for laeger·2014
Same author

Study protocol: cost-effectiveness of multidisciplinary nutritional support for undernutrition in older adults in nursing home and home-care: cluster randomized controlled trial.

Nutrition journal·2014

Related Experiment Video

Updated: Jul 6, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

[Economic feasibility study and reimbursement rules--illustrated by a concrete example].

Hans Keiding1, Ole Faergeman

  • 1Økonomisk Institut, og Arhus Universitetshospital, Arhus Sygehus, Medicinsk Kardiologisk Afdeling A. Hans.Keiding@econ.ku.dk

Ugeskrift for Laeger
|March 28, 2008
PubMed
Summary

Reimbursement policies significantly impact drug cost-effectiveness. Evaluating reimbursement alongside medical effects prevents patient treatment gaps and resource waste, improving healthcare efficiency.

Related Experiment Videos

Last Updated: Jul 6, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • Cost-Effectiveness Analysis

Context:

  • Economic factors heavily influence pharmaceutical reimbursement decisions.
  • The impact of reimbursement structures (individual, conditional, general) on cost-effectiveness is often underestimated.
  • Healthcare resource allocation requires careful consideration of treatment accessibility and justification.

Purpose:

  • To analyze how different pharmaceutical reimbursement models affect cost-effectiveness.
  • To incorporate the risk of undertreatment and resource wastage into cost-effectiveness calculations.
  • To illustrate a method for assessing reimbursement's influence on drug cost-effectiveness using a statin therapy example.

Summary:

  • Individual-based reimbursement for statins (1994-1998) proved cost-ineffective due to preventing appropriate patient treatment.
  • Conditional reimbursement introduced after 1998 demonstrated improved cost-effectiveness.
  • The study highlights that including reimbursement regimes in cost-effectiveness assessments is crucial.

Impact:

  • This approach helps prevent the loss of patients eligible for cost-effective treatments.
  • It provides a framework for optimizing healthcare resource allocation.
  • Informing policy decisions to enhance the efficiency of pharmaceutical interventions.